Incipient diabetic retinopathy - Insights from an experimental model

Ophthalmologica

Volumn 221, Issue 4, 2007, Pages 269-274

  Feng, Yuxi ^a   Vom Hagen, Franziska ^a   Lin, Jihong ^a   Hammes, Hans Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Acellular capillary; Ang Tie; Diabetic retinopathy; Pericyte

Indexed keywords

ADVANCED GLYCATION END PRODUCT; GLUCOSE; HYPOXIA INDUCIBLE FACTOR 1; PROTEIN; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE;

ANGIOGENESIS; CYTOLOGY; DIABETES MELLITUS; DIABETIC RETINOPATHY; EXPERIMENTAL MODEL; GLUCOSE INTAKE; HUMAN; HYPERGLYCEMIA; INCIDENCE; MOUSE STRAIN; NONHUMAN; OXIDATIVE STRESS; PATHOLOGY; PERICYTE; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; REVIEW;

ANIMALS; DIABETIC RETINOPATHY; HUMANS; MODELS, THEORETICAL; PERICYTES; RETINAL VESSELS;

EID: 34250723764     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000101930     Document Type: Review

References (39)

1. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 2000;342:381-389.
2. Gaede P, Vedel P, Larsen N, Jensen GVH, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-393.
3. Frank RN: Diabetic retinopathy. N Engl J Med 2004;350:48-58.
4. Brownlee M: Biochemistry and molecular cell biology of diabetic complications. Nature 2001;414:813-820.
5. Cogan DG, Toussaint D, Kuwabara T: Retinal vascular pattern. IV. Diabetic retinopathy. Arch Ophthalmol 1961;66:366-378.
6. Engerman R, Finkelstein D, Aguirre G, Diddie KR, Fox RR, Frank RN, Varma SD: Ocular complications. Diabetes 1982;31(suppl 1):82-88.
7. Cogan DG, Kuwabara T: The mural cell in perspective. Arch Ophthalmol 1967;78:133-139.
8. Kohner EM, Henkind P: Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol 1970;69:403-414.
9. Miller JW, Adamis AP, Shima DT, D'Amore PA, Moulton RS, O'Reilly MS, Folkman J, Dvorak HF, Brown LF, Berse B, et al: Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 1994;145:574-584.
10. Ashton N: Pathogenesis of diabetic retinopathy; in Little HL, Jack RL, Patz AP, Forsham PH (eds): Diabetic Retinopathy. New York, Thieme-Stratton Inc, 1983, pp 85-106.
11. Allt G, Lawrenson JG: Pericytes: cell biology and pathology. Cells Tissues Organs 2001;169:1-11.
12. Von Tell D, Armulik A, Betsholtz C: Pericytes and vascular stability. Exp Cell Res 2006;312:623-629.
13. Tidhar A, Reichenstein M, Cohen D, Faerman A, Copeland NG, Gilbert DJ, Jenkins NA, Shani M: A novel transgenic marker for migrating limb muscle precursors and for vascular smooth muscle cells. Dev Dyn 2001;220:60-73.
14. Morikawa S, Baluk P, Kaidoh T, Haskell A, Jain RK, McDonald DM: Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 2002;160:985-1000.
15. Hoffmann J, Feng Y, vom Hagen F, Hillenbrand A, Lin J, Erber R, Vajkoczy P, Gourzoulidou E, Waldmann H, Giannis, A, Wolburg H, Shani M, Jaeger V, Weich HA, Preissner KT, Hoffmann S, Deutsch U, Hammes HP: Endothelial survival factors and spatial completion, but not pericyte coverage of retinal capillaries determine vessel plasticity. FASEB J 2005;19:2035-2036.
16. Büscher C, Weis A, Wohrle M, Bretzel RG, Cohen AM, Federlin K: Islet transplantation in experimental diabetes of the rat. XII. Effect on diabetic retinopathy: morphological findings and morphometrical evaluation. Horm Metab Res 1989;21:227-231.
17. Hammes HP, Bartmann A, Engel L, Wülfroth P: Antioxidant treatment of experimental diabetic retinopathy with nicanartine. Diabetologia 1997;40:629-634.
18. Stitt AW, Li YM, Gardiner TA, Bucala R, Archer DB, Vlassara H: Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. Am J Pathol 1997;150:523-531.
19. Yamagishi S, Fujimori H, Yonekura H, Tanaka N, Yamamoto H: Advanced glycation endproducts accelerate calcification in microvascular pericytes. Biochem Biophys Res Commun 1999;258:353-357.
20. Lyons TJ, Li W, Wojciechowski B, Wells-Knecht MC, Wells-Knecht KJ, Jenkins AJ: Aminoguanidine and the effects of modified LDL on cultured retinal capillary cells. Invest Ophthalmol Vis Sci 2000;41:1176-1180.
21. Romeo G, Liu WH, Asnaghi V, Kern TS, Lorenzi M: Activation of nuclear factor-B induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes 2002;51:2241-2248.
22. Hammes HP: Pericytes and the pathogenesis of diabetic retinopathy. Horm Metab Res 2005;37(suppl 1):39-43.
23. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD: Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis Cell 1996;87:1171-1180.
24. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD: Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996;87:1161-1169.
25. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara, Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995;376:70-74.
26. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997;277:55-60.
27. Hanahan D: Signaling vascular morphogenesis and maintenance. Science 1997;277:48-50.
28. Holash J, Wiegand SJ, Yancopoulos GD: New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 1999;18:5356-5362.
29. Carmeliet P: Angiogenesis in health and disease. Nat Med 2003;9:653-660.
30. Jain R: Molecular regulation of vessel maturation. Nat Med 2003;9:685-693.
31. Hammes HP, Lin J, Wagner P, Feng Y, vom Hagen F, Krzizok, T, Renner O, Breier G, Brownlee M, Deutsch U: Angiopoietin-2 causes pericyte dropout in the normal retina: evidence for involvement in diabetic retinopathy. Diabetes 2004;53:1104-1110.
32. Thornalley PJ: Glyoxalase I - structure, function and a critical role in the enzymatic defence against glycation. Biochem Soc Trans 2003;31:1343-1248.
33. Hammes HP, Martin S, Federlin K, Geisen K, Brownlee M: Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. Proc Natl Acad Sci USA 1991;88:11555-11558.
34. Stitt A, Gardiner TA, Alderson NL, Canning P, Frizzell N, Duffy N, Boyle C, Januszewski AS, Chachich M, Baynes JW, Thorpe SR: The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 2002;51:2826-2832.
35. Yao D, Taguchi T, Matsumura T, Pestell R, Edelstein D;Giardino I, Suske G, Ahmed N, Thornalley PJ, Sarthy VP, Hammes HP, Brownlee M: Methylglyoxal modification of mSin3A links altered glycolysis to angiopoietin-2 transcription: a novel mechanism for regulating gene expression. Cell 2006;124:275-286.
36. Hammes HP, Du X, Edelstein D, Taguchi T, Matsumara T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M: Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 2003;9:294-299.
37. Zheng L, Szabo C, Kern TS: Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes 2004;53:2960-2967.
38. Lin J, Bierhaus A, Bugert P, Dietrich N, Feng Y, vom Hagen F, Nawroth P, Brownlee M, Hammes HP: Effect of R-(+)-α-lipoic acid on experimental diabetic retinopathy. Diabetologia 2006;49:1089-1096.
39. Hoffmann J, Alt A, Lin J, Lochnit G, Schubert U, Schleicher E, Chavakis T, Brownlee M, Van der Woude FJ, Preissner KT, Hammes HP: Tenilsetam prevents early diabetic retinopathy without correcting pericyte loss. Thromb Haemost 2006;95:689-695.